For this study, outcomes were compared between 2 groups of patients with myasthenia gravis: those who developed exacerbations ...

The FDA has granted Priority Review to nipocalimab for the treatment of antibody positive patients with generalized myasthenia gravis.

In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent ...

This SPA agreement marks an important milestone in the development of Descartes-08 for MG, providing critical regulatory clarity and a clear path toward potential approval,” said Carsten Brunn, Ph.D., ...

Nature Research Intelligence Topics enable transformational understanding and discovery in research by categorising any document into meaningful, accessible topics. Read this blog to understand ...

Jan. 15, 2025 — New observational data and simulation models have confirmed a new type of planet unlike anything found in the Solar System. This provides another piece of the puzzle to ...

The approach offers long-term, real-time monitoring ... New Understanding of the Gut Immune System May Hold Promise for Crohn's Disease Patients Mar. 15, 2024 — Scientists uncovered an ...

Myasthenia gravis is an antibody-mediated disease of the motor endplate that leads to impaired neuromuscular transmission. 1 Pathogenic antibodies directed against antigens such as the postsynaptic ...

Respiratory tract diseases are illnesses that affect components of the respiratory system, including the nasal passages, the bronchi and the lungs. They range from acute infections, such as ...

Graviss Hospitality Ltd., incorporated in the year 1959, is a Small Cap company (having a market cap of Rs 325.73 Crore) operating in Tourism & Hospitality sector. Graviss Hospitality Ltd. key ...